Corticosteroids and mania: A systematic review
CONCLUSION: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias De Bock Pascal Sienaert Source Type: research

Corticosteroids and mania: A systematic review
CONCLUSION: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias De Bock Pascal Sienaert Source Type: research

Corticosteroids and mania: A systematic review
CONCLUSION: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias De Bock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research

Corticosteroids and mania: a systematic review
Conclusion: Our findings suggest that mania is a common side-effect of corticosteroid use, particularly in prednisone equivalent doses above 40 mg. These findings hold practical significance for clinicians and provide insights into potential interventions, including careful monitoring, dose adjustments, and consideration of psychotropic medications when managing corticosteroid-induced mania.PMID:38363330 | DOI:10.1080/15622975.2024.2312572 (Source: The World Journal of Biological Psychiatry)
Source: The World Journal of Biological Psychiatry - February 16, 2024 Category: Psychiatry Authors: Mathias DeBock Pascal Sienaert Source Type: research